Scott A Wildman

Predicting kinase inhibitors using bioactivity matrix derived informer sets

Stephen J. Wright, Julie C. Mitchell, Anthony Gitter, 2019, bioRxiv.

Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening

Huikun Zhang, F Michael Hoffmann, Scott A Wildman, 2017, J. Chem. Inf. Model..

Approaches to virtual screening and screening library selection.

Scott A Wildman, S. Wildman, 2013, Current pharmaceutical design.

Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18.

Matthieu Schapira, Scott A Wildman, Emily A Hull-Ryde, 2016, ACS infectious diseases.

Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models

Huan Yang, Jun Ren, Scott A Wildman, 2019, Cell Death & Disease.

Three-dimensional molecular descriptors and a novel QSAR method.

Gordon M Crippen, Scott A Wildman, G. Crippen, 2002, Journal of molecular graphics & modelling.